Literature DB >> 23504319

Protein kinase A regulates MYC protein through transcriptional and post-translational mechanisms in a catalytic subunit isoform-specific manner.

Achuth Padmanabhan1, Xiang Li, Charles J Bieberich.   

Abstract

MYC levels are tightly regulated in cells, and deregulation is associated with many cancers. In this report, we describe the existence of a MYC-protein kinase A (PKA)-polo-like kinase 1 (PLK1) signaling loop in cells. We report that sequential MYC phosphorylation by PKA and PLK1 protects MYC from proteasome-mediated degradation. Interestingly, short term pan-PKA inhibition diminishes MYC level, whereas prolonged PKA catalytic subunit α (PKACα) knockdown, but not PKA catalytic subunit β (PKACβ) knockdown, increases MYC. We show that the short term effect of pan-PKA inhibition on MYC is post-translational and the PKACα-specific long term effect on MYC is transcriptional. These data also reveal distinct functional roles among PKA catalytic isoforms in MYC regulation. We attribute this effect to differential phosphorylation selectivity among PKA catalytic subunits, which we demonstrate for multiple substrates. Further, we also show that MYC up-regulates PKACβ, transcriptionally forming a proximate positive feedback loop. These results establish PKA as a regulator of MYC and highlight the distinct biological roles of the different PKA catalytic subunits.

Entities:  

Keywords:  Cancer Biology; MYC; Phosphorylation; Polo-like Kinase 1 (PLK1); Post-translational Modification; Protein Kinase A (PKA)

Mesh:

Substances:

Year:  2013        PMID: 23504319      PMCID: PMC3656272          DOI: 10.1074/jbc.M112.432377

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

1.  Antisense-mediated depletion of p300 in human cells leads to premature G1 exit and up-regulation of c-MYC.

Authors:  S Kolli; A M Buchmann; J Williams; S Weitzman; B Thimmapaya
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

2.  A molecular signature of metastasis in primary solid tumors.

Authors:  Sridhar Ramaswamy; Ken N Ross; Eric S Lander; Todd R Golub
Journal:  Nat Genet       Date:  2002-12-09       Impact factor: 38.330

3.  Improved siRNA-mediated silencing in refractory adherent cell lines by detachment and transfection in suspension.

Authors:  Mohammed Amarzguioui
Journal:  Biotechniques       Date:  2004-05       Impact factor: 1.993

4.  A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells.

Authors:  Elizabeth Yeh; Melissa Cunningham; Hugh Arnold; Dawn Chasse; Teresa Monteith; Giovanni Ivaldi; William C Hahn; P Todd Stukenberg; Shirish Shenolikar; Takafumi Uchida; Christopher M Counter; Joseph R Nevins; Anthony R Means; Rosalie Sears
Journal:  Nat Cell Biol       Date:  2004-03-14       Impact factor: 28.824

5.  Extreme instability of myc mRNA in normal and transformed human cells.

Authors:  C Dani; J M Blanchard; M Piechaczyk; S El Sabouty; L Marty; P Jeanteur
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

6.  c-MYC activates protein kinase A (PKA) by direct transcriptional activation of the PKA catalytic subunit beta (PKA-Cbeta) gene.

Authors:  Kou-Juey Wu; Michela Mattioli; Herbert C Morse; Riccardo Dalla-Favera
Journal:  Oncogene       Date:  2002-11-07       Impact factor: 9.867

7.  Polo-like kinase-1 is a target of the DNA damage checkpoint.

Authors:  V A Smits; R Klompmaker; L Arnaud; G Rijksen; E A Nigg; R H Medema
Journal:  Nat Cell Biol       Date:  2000-09       Impact factor: 28.824

8.  Protein kinase substrate recognition studied using the recombinant catalytic domain of AMP-activated protein kinase and a model substrate.

Authors:  John W Scott; David G Norman; Simon A Hawley; Luke Kontogiannis; D Grahame Hardie
Journal:  J Mol Biol       Date:  2002-03-22       Impact factor: 5.469

9.  Regulation of c-myc mRNA decay by translational pausing in a coding region instability determinant.

Authors:  Ira Lemm; Jeff Ross
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

10.  The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation.

Authors:  Markus Welcker; Amir Orian; Jianping Jin; Jonathan E Grim; Jonathan A Grim; J Wade Harper; Robert N Eisenman; Bruce E Clurman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-18       Impact factor: 11.205

View more
  18 in total

1.  Cross-talk between PKA-Cβ and p65 mediates synergistic induction of PDE4B by roflumilast and NTHi.

Authors:  Seiko Susuki-Miyata; Masanori Miyata; Byung-Cheol Lee; Haidong Xu; Hirofumi Kai; Chen Yan; Jian-Dong Li
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-23       Impact factor: 11.205

2.  PLK1 Inhibition Targets Myc-Activated Malignant Glioma Cells Irrespective of Mismatch Repair Deficiency-Mediated Acquired Resistance to Temozolomide.

Authors:  Fumi Higuchi; Alexandria L Fink; Juri Kiyokawa; Julie J Miller; Mara V A Koerner; Daniel P Cahill; Hiroaki Wakimoto
Journal:  Mol Cancer Ther       Date:  2018-09-14       Impact factor: 6.261

Review 3.  The role of aurora A and polo-like kinases in high-risk lymphomas.

Authors:  Carlos Murga-Zamalloa; Kedar V Inamdar; Ryan A Wilcox
Journal:  Blood Adv       Date:  2019-06-11

4.  miR-17-92 and miR-106b-25 clusters regulate beta cell mitotic checkpoint and insulin secretion in mice.

Authors:  Amitai D Mandelbaum; Sharon Kredo-Russo; Danielle Aronowitz; Nadav Myers; Eran Yanowski; Agnes Klochendler; Avital Swisa; Yuval Dor; Eran Hornstein
Journal:  Diabetologia       Date:  2019-06-11       Impact factor: 10.122

5.  Activating PRKACB somatic mutation in cortisol-producing adenomas.

Authors:  Stéphanie Espiard; Matthias J Knape; Kerstin Bathon; Guillaume Assié; Marthe Rizk-Rabin; Simon Faillot; Windy Luscap-Rondof; Daniel Abid; Laurence Guignat; Davide Calebiro; Friedrich W Herberg; Constantine A Stratakis; Jérôme Bertherat
Journal:  JCI Insight       Date:  2018-04-19

6.  DNAJB1-PRKACA is specific for fibrolamellar carcinoma.

Authors:  Rondell P Graham; Long Jin; Darlene L Knutson; Sara M Kloft-Nelson; Patricia T Greipp; Nina Waldburger; Stephanie Roessler; Thomas Longerich; Lewis R Roberts; Andre M Oliveira; Kevin C Halling; Peter Schirmacher; Michael S Torbenson
Journal:  Mod Pathol       Date:  2015-02-20       Impact factor: 7.842

7.  Quantifying Kinase-Specific Phosphorylation Stoichiometry Using Stable Isotope Labeling In a Reverse In-Gel Kinase Assay.

Authors:  Xiang Li; Jonathan T Cox; Weiliang Huang; Maureen Kane; Keqi Tang; Charles J Bieberich
Journal:  Anal Chem       Date:  2016-11-18       Impact factor: 6.986

8.  An in vivo screening system to identify tumorigenic genes.

Authors:  T Ihara; Y Hosokawa; K Kumazawa; K Ishikawa; J Fujimoto; M Yamamoto; T Muramkami; N Goshima; E Ito; S Watanabe; K Semba
Journal:  Oncogene       Date:  2016-10-03       Impact factor: 9.867

Review 9.  The role of polo-like kinase 1 in carcinogenesis: cause or consequence?

Authors:  Brian D Cholewa; Xiaoqi Liu; Nihal Ahmad
Journal:  Cancer Res       Date:  2013-11-21       Impact factor: 12.701

10.  Zinc Oxide nanoparticles induce oxidative and proteotoxic stress in ovarian cancer cells and trigger apoptosis Independent of p53-mutation status.

Authors:  Achuth Padmanabhan; M Kaushik; R Niranjan; JoAnne S Richards; Brandon Ebright; G Devanand Venkatasubbu
Journal:  Appl Surf Sci       Date:  2019-09       Impact factor: 6.707

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.